Toronto, Canada

Michael Buchanan

This inventor holds 2 USPTO granted patents. Top assignee: Nestec S.a.. Active years: 1992-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Buchanan. Retrieved from https://idiyas.com/inventor/michael-buchanan-8y80g0rl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1992-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Michael Buchanan

Introduction

Michael Buchanan is an accomplished inventor based in Toronto, Canada. He has made significant contributions to the field of biomedical research, particularly in the area of lipid applications for health benefits. With a total of 2 patents, his work focuses on reducing thrombogenicity and inhibiting cancer cell metastases.

Latest Patents

One of Michael's latest patents is titled "Reduction of thrombogenicity with lipids of blackcurrant seed." This invention utilizes lipids obtained from blackcurrant seed to reduce the thrombogenicity of blood vessels in humans. Another notable patent is "Inhibition of cell adhesion for reducing cancer cell metastases," which employs the same lipids to prevent the proliferation and dissemination of cancerous metastases in patients.

Career Highlights

Michael currently works at Nestec S.A., where he continues to innovate and develop new solutions in the field of health and nutrition. His research has the potential to significantly impact patient care and treatment options.

Collaborations

Michael collaborates with talented professionals in his field, including Gayle Crozier-Willi and Mathilde Fleith. Their combined expertise enhances the research and development efforts at Nestec S.A.

Conclusion

Michael Buchanan's innovative work in lipid applications demonstrates his commitment to advancing medical science and improving health outcomes. His patents reflect a dedication to addressing critical health challenges through research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…